In contrast to the SNU475 and HUH7 cells, Wnt3a treatment mostly mitigated the cancer effect by reversing the differential regulation of lipids in Hep3B cells (Fig. S4C, 113 lipids represented in green bars, Table S2). The gene discussed is WNT3A; the disease is cancer.